123 related articles for article (PubMed ID: 36184519)
1. Naltrexone Transport by a Proton-Coupled Organic Cation Antiporter in hCMEC/D3 Cells, an in Vitro Human Blood-Brain Barrier Model.
Kitamura A; Higuchi K; Kurosawa T; Okura T; Kubo Y; Deguchi Y
Biol Pharm Bull; 2022; 45(10):1585-1589. PubMed ID: 36184519
[TBL] [Abstract][Full Text] [Related]
2. Proton-coupled organic cation antiporter-mediated uptake of apomorphine enantiomers in human brain capillary endothelial cell line hCMEC/D3.
Okura T; Higuchi K; Kitamura A; Deguchi Y
Biol Pharm Bull; 2014; 37(2):286-91. PubMed ID: 24257040
[TBL] [Abstract][Full Text] [Related]
3. A proton-coupled organic cation antiporter is involved in the blood-brain barrier transport of Aconitum alkaloids.
Cong J; Ruan Y; Lyu Q; Qin X; Qi X; Liu W; Kang L; Zhang J; Wu C
J Ethnopharmacol; 2020 Apr; 252():112581. PubMed ID: 31968215
[TBL] [Abstract][Full Text] [Related]
4. Memantine transport by a proton-coupled organic cation antiporter in hCMEC/D3 cells, an in vitro human blood-brain barrier model.
Higuchi K; Kitamura A; Okura T; Deguchi Y
Drug Metab Pharmacokinet; 2015 Apr; 30(2):182-7. PubMed ID: 25857234
[TBL] [Abstract][Full Text] [Related]
5. Structural Requirements for Uptake of Diphenhydramine Analogs into hCMEC/D3 Cells Via the Proton-Coupled Organic Cation Antiporter.
Tega Y; Tabata H; Kurosawa T; Kitamura A; Itagaki F; Oshitari T; Deguchi Y
J Pharm Sci; 2021 Jan; 110(1):397-403. PubMed ID: 32898521
[TBL] [Abstract][Full Text] [Related]
6. Functional expression of a proton-coupled organic cation (H+/OC) antiporter in human brain capillary endothelial cell line hCMEC/D3, a human blood-brain barrier model.
Shimomura K; Okura T; Kato S; Couraud PO; Schermann JM; Terasaki T; Deguchi Y
Fluids Barriers CNS; 2013 Jan; 10(1):8. PubMed ID: 23351963
[TBL] [Abstract][Full Text] [Related]
7. The putative proton-coupled organic cation antiporter is involved in uptake of triptans into human brain capillary endothelial cells.
Svane N; Pedersen ABV; Rodenberg A; Ozgür B; Saaby L; Bundgaard C; Kristensen M; Tfelt-Hansen P; Brodin B
Fluids Barriers CNS; 2024 May; 21(1):39. PubMed ID: 38711118
[TBL] [Abstract][Full Text] [Related]
8. The mystery of the human proton-organic cation antiporter: One transport protein or many?
Sachkova A; Jensen O; Dücker C; Ansari S; Brockmöller J
Pharmacol Ther; 2022 Nov; 239():108283. PubMed ID: 36162727
[TBL] [Abstract][Full Text] [Related]
9. Transport characteristics of tramadol in the blood-brain barrier.
Kitamura A; Higuchi K; Okura T; Deguchi Y
J Pharm Sci; 2014 Oct; 103(10):3335-41. PubMed ID: 25175482
[TBL] [Abstract][Full Text] [Related]
10. Involvement of Proton-Coupled Organic Cation Antiporter in Varenicline Transport at Blood-Brain Barrier of Rats and in Human Brain Capillary Endothelial Cells.
Kurosawa T; Higuchi K; Okura T; Kobayashi K; Kusuhara H; Deguchi Y
J Pharm Sci; 2017 Sep; 106(9):2576-2582. PubMed ID: 28454746
[TBL] [Abstract][Full Text] [Related]
11. Substrates of the Human Brain Proton-Organic Cation Antiporter and Comparison with Organic Cation Transporter 1 Activities.
Doetsch DA; Ansari S; Jensen O; Gebauer L; Dücker C; Brockmöller J; Sachkova A
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955563
[TBL] [Abstract][Full Text] [Related]
12. Involvement of a proton-coupled organic cation antiporter in the blood-brain barrier transport of amantadine.
Suzuki T; Aoyama T; Suzuki N; Kobayashi M; Fukami T; Matsumoto Y; Tomono K
Biopharm Drug Dispos; 2016 Sep; 37(6):323-35. PubMed ID: 27146715
[TBL] [Abstract][Full Text] [Related]
13. How do psychostimulants enter the human brain? Analysis of the role of the proton-organic cation antiporter.
Sachkova A; Doetsch DA; Jensen O; Brockmöller J; Ansari S
Biochem Pharmacol; 2021 Oct; 192():114751. PubMed ID: 34464621
[TBL] [Abstract][Full Text] [Related]
14. [The blood-brain barrier transport mechanism controlling analgesic effects of opioid drugs in CNS].
Okura T; Higuchi K; Deguchi Y
Yakugaku Zasshi; 2015; 135(5):697-702. PubMed ID: 25948304
[TBL] [Abstract][Full Text] [Related]
15. Involvement of the pyrilamine transporter, a putative organic cation transporter, in blood-brain barrier transport of oxycodone.
Okura T; Hattori A; Takano Y; Sato T; Hammarlund-Udenaes M; Terasaki T; Deguchi Y
Drug Metab Dispos; 2008 Oct; 36(10):2005-13. PubMed ID: 18606742
[TBL] [Abstract][Full Text] [Related]
16. A face-to-face comparison of claudin-5 transduced human brain endothelial (hCMEC/D3) cells with porcine brain endothelial cells as blood-brain barrier models for drug transport studies.
Gericke B; Römermann K; Noack A; Noack S; Kronenberg J; Blasig IE; Löscher W
Fluids Barriers CNS; 2020 Aug; 17(1):53. PubMed ID: 32843059
[TBL] [Abstract][Full Text] [Related]
17. Organic cation transporter 1 (OCT1) is involved in pentamidine transport at the human and mouse blood-brain barrier (BBB).
Sekhar GN; Georgian AR; Sanderson L; Vizcay-Barrena G; Brown RC; Muresan P; Fleck RA; Thomas SA
PLoS One; 2017; 12(3):e0173474. PubMed ID: 28362799
[TBL] [Abstract][Full Text] [Related]
18. Memantine transport across the mouse blood-brain barrier is mediated by a cationic influx H+ antiporter.
Mehta DC; Short JL; Nicolazzo JA
Mol Pharm; 2013 Dec; 10(12):4491-8. PubMed ID: 24098999
[TBL] [Abstract][Full Text] [Related]
19. Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC/D3 as a human blood-brain barrier model.
Ohtsuki S; Ikeda C; Uchida Y; Sakamoto Y; Miller F; Glacial F; Decleves X; Scherrmann JM; Couraud PO; Kubo Y; Tachikawa M; Terasaki T
Mol Pharm; 2013 Jan; 10(1):289-96. PubMed ID: 23137377
[TBL] [Abstract][Full Text] [Related]
20. A review on in vitro model of the blood-brain barrier (BBB) based on hCMEC/D3 cells.
Qi D; Lin H; Hu B; Wei Y
J Control Release; 2023 Jun; 358():78-97. PubMed ID: 37076016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
